12532 related articles for article (PubMed ID: 10436774)
21. Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas.
Goggins M; Schutte M; Lu J; Moskaluk CA; Weinstein CL; Petersen GM; Yeo CJ; Jackson CE; Lynch HT; Hruban RH; Kern SE
Cancer Res; 1996 Dec; 56(23):5360-4. PubMed ID: 8968085
[TBL] [Abstract][Full Text] [Related]
22. The molecular genetics of pancreatic cancer.
Howe JR; Conlon KC
Surg Oncol; 1997; 6(1):1-18. PubMed ID: 9364657
[TBL] [Abstract][Full Text] [Related]
23. Pancreatic cancer genetics.
Efthimiou E; Crnogorac-Jurcevic T; Lemoine NR
Pancreatology; 2001; 1(6):571-5. PubMed ID: 12120238
[TBL] [Abstract][Full Text] [Related]
24. [Familial pancreatic cancer].
Zalatnai A
Magy Onkol; 2006; 50(2):163-8. PubMed ID: 16888680
[TBL] [Abstract][Full Text] [Related]
25. Recent discoveries in cancer genetics of exocrine pancreatic neoplasia.
Hahn SA; Schmiegel WH
Digestion; 1998 Aug; 59(5):493-501. PubMed ID: 9705534
[TBL] [Abstract][Full Text] [Related]
26. Genetic testing by cancer site: pancreas.
Axilbund JE; Wiley EA
Cancer J; 2012; 18(4):350-4. PubMed ID: 22846737
[TBL] [Abstract][Full Text] [Related]
27. A histomorphologic comparison of familial and sporadic pancreatic cancers.
Singhi AD; Ishida H; Ali SZ; Goggins M; Canto M; Wolfgang C; Meriden Z; Roberts N; Klein AP; Hruban RH
Pancreatology; 2015; 15(4):387-391. PubMed ID: 25959245
[TBL] [Abstract][Full Text] [Related]
28. Molecular pathogenesis of pancreatic cancer.
Hilgers W; Rosty C; Hahn SA
Hematol Oncol Clin North Am; 2002 Feb; 16(1):17-35, v. PubMed ID: 12063826
[TBL] [Abstract][Full Text] [Related]
29. Frequent deletions of tumor suppressor genes in pure pancreatic juice from patients with tumoral or nontumoral pancreatic diseases.
Costentin L; Pagès P; Bouisson M; Berthelémy P; Buscail L; Escourrou J; Pradayrol L; Vaysse N
Pancreatology; 2002; 2(1):17-25. PubMed ID: 12120000
[TBL] [Abstract][Full Text] [Related]
30. No evidence for germline mutations of the LKB1/STK11 gene in familial pancreatic carcinoma.
Grützmann R; McFaul C; Bartsch DK; Sina-Frey M; Rieder H; Koch R; McCarthy E; Greenhalf W; Neoptolemos JP; Saeger HD; Pilarsky C
Cancer Lett; 2004 Oct; 214(1):63-8. PubMed ID: 15331174
[TBL] [Abstract][Full Text] [Related]
31. Molecular pathogenesis of pancreatic adenocarcinoma: potential clinical implications.
Talar-Wojnarowska R; Malecka-Panas E
Med Sci Monit; 2006 Sep; 12(9):RA186-93. PubMed ID: 16940943
[TBL] [Abstract][Full Text] [Related]
32. Pathology of incipient pancreatic cancer.
Hruban RH; Wilentz RE; Goggins M; Offerhaus GJ; Yeo CJ; Kern SE
Ann Oncol; 1999; 10 Suppl 4():9-11. PubMed ID: 10436775
[TBL] [Abstract][Full Text] [Related]
33. Frequent RASSF1A promoter hypermethylation and K-ras mutations in pancreatic carcinoma.
Dammann R; Schagdarsurengin U; Liu L; Otto N; Gimm O; Dralle H; Boehm BO; Pfeifer GP; Hoang-Vu C
Oncogene; 2003 Jun; 22(24):3806-12. PubMed ID: 12802288
[TBL] [Abstract][Full Text] [Related]
34. Familial pancreatic cancer and the genetics of pancreatic cancer.
Lumadue JA; Griffin CA; Osman M; Hruban RH
Surg Clin North Am; 1995 Oct; 75(5):845-55. PubMed ID: 7660249
[TBL] [Abstract][Full Text] [Related]
35. Low incidence of BRCA2 mutations in breast carcinoma and other cancers.
Teng DH; Bogden R; Mitchell J; Baumgard M; Bell R; Berry S; Davis T; Ha PC; Kehrer R; Jammulapati S; Chen Q; Offit K; Skolnick MH; Tavtigian SV; Jhanwar S; Swedlund B; Wong AK; Kamb A
Nat Genet; 1996 Jun; 13(2):241-4. PubMed ID: 8640236
[TBL] [Abstract][Full Text] [Related]
36. Hereditary pancreatic cancer.
Lynch HT; Brand RE; Deters CA; Shaw TG; Lynch JF
Pancreatology; 2001; 1(5):466-71. PubMed ID: 12120226
[TBL] [Abstract][Full Text] [Related]
37. Biliopancreatic malignancy: screening the at risk patient with molecular markers.
Caldas C
Ann Oncol; 1999; 10 Suppl 4():153-6. PubMed ID: 10436811
[TBL] [Abstract][Full Text] [Related]
38. Molecular advances in pancreatic cancer.
Lemoine NR
Digestion; 1997; 58(6):550-6. PubMed ID: 9438601
[TBL] [Abstract][Full Text] [Related]
39. Molecular genetics and related developments in pancreatic cancer.
Hruban RH; Goggins M; Kern SE
Curr Opin Gastroenterol; 1999 Sep; 15(5):404-9. PubMed ID: 17023981
[TBL] [Abstract][Full Text] [Related]
40. K-ras and p53 in pancreatic cancer: association with medical history, histopathology, and environmental exposures in a population-based study.
Slebos RJ; Hoppin JA; Tolbert PE; Holly EA; Brock JW; Zhang RH; Bracci PM; Foley J; Stockton P; McGregor LM; Flake GP; Taylor JA
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1223-32. PubMed ID: 11097231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
